These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 31678992)

  • 1. Dietary and Pharmacological Fatty Acids and Cardiovascular Health.
    Wu H; Xu L; Ballantyne CM
    J Clin Endocrinol Metab; 2020 Apr; 105(4):1030-45. PubMed ID: 31678992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triglyceride-lowering and anti-inflammatory mechanisms of omega-3 polyunsaturated fatty acids for atherosclerotic cardiovascular risk reduction.
    Liu QK
    J Clin Lipidol; 2021; 15(4):556-568. PubMed ID: 34172393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ω3 long-chain polyunsaturated fatty acids in reducing cardio-metabolic risk factors.
    Abeywardena MY; Patten GS
    Endocr Metab Immune Disord Drug Targets; 2011 Sep; 11(3):232-46. PubMed ID: 21831036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of omega-3, omega-6, and total dietary polyunsaturated fatty acid supplementation in patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis.
    Luo S; Hou H; Wang Y; Li Y; Zhang L; Zhang H; Jin Q; Wu G; Wang X
    Food Funct; 2024 Feb; 15(3):1208-1222. PubMed ID: 38224465
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of Cardiovascular Events with Omega-3 Polyunsaturated Fatty Acids and the Mechanism Involved.
    Watanabe Y; Tatsuno I
    J Atheroscler Thromb; 2020 Mar; 27(3):183-198. PubMed ID: 31582621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Impact of Nutritional Supplementation With Omega-3 Fatty Acids: JACC Focus Seminar.
    Weinberg RL; Brook RD; Rubenfire M; Eagle KA
    J Am Coll Cardiol; 2021 Feb; 77(5):593-608. PubMed ID: 33538258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 fatty acids for the prevention of atherosclerotic cardiovascular disease.
    Barry AR; Dixon DL
    Pharmacotherapy; 2021 Dec; 41(12):1056-1065. PubMed ID: 34431129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fish Oil and Cardiometabolic Diseases: Recent Updates and Controversies.
    Tummala R; Ghosh RK; Jain V; Devanabanda AR; Bandyopadhyay D; Deedwania P; Aronow WS
    Am J Med; 2019 Oct; 132(10):1153-1159. PubMed ID: 31077653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with omega-3 polyunsaturated fatty acids does not improve endothelial function in patients with type 2 diabetes and very high cardiovascular risk: A randomized, double-blind, placebo-controlled study (Omega-FMD).
    Siniarski A; Haberka M; Mostowik M; Gołębiowska-Wiatrak R; Poręba M; Malinowski KP; Gąsior Z; Konduracka E; Nessler J; Gajos G
    Atherosclerosis; 2018 Apr; 271():148-155. PubMed ID: 29518747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid.
    Siriwardhana N; Kalupahana NS; Moustaid-Moussa N
    Adv Food Nutr Res; 2012; 65():211-22. PubMed ID: 22361189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid concentration of plasma, muscle, adipose and liver from beef heifers fed an encapsulated n-3 polyunsaturated fatty acid supplement.
    Hennessy AA; Kenny DA; Byrne CJ; Childs S; Ross RP; Devery R; Stanton C
    Animal; 2021 Jan; 15(1):100039. PubMed ID: 33516004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids.
    Burke MF; Burke FM; Soffer DE
    Curr Atheroscler Rep; 2017 Nov; 19(12):60. PubMed ID: 29116404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored.
    Calder PC
    Clin Sci (Lond); 2004 Jul; 107(1):1-11. PubMed ID: 15132735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDS.
    Handelsman Y; Shapiro MD
    Endocr Pract; 2017 Jan; 23(1):100-112. PubMed ID: 27819772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
    Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
    Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary omega-6 fatty acid lowering increases bioavailability of omega-3 polyunsaturated fatty acids in human plasma lipid pools.
    Taha AY; Cheon Y; Faurot KF; Macintosh B; Majchrzak-Hong SF; Mann JD; Hibbeln JR; Ringel A; Ramsden CE
    Prostaglandins Leukot Essent Fatty Acids; 2014 May; 90(5):151-7. PubMed ID: 24675168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in saturated fat intake for cardiovascular disease.
    Hooper L; Martin N; Abdelhamid A; Davey Smith G
    Cochrane Database Syst Rev; 2015 Jun; (6):CD011737. PubMed ID: 26068959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do we need 'new' omega-3 polyunsaturated fatty acids formulations?
    Cicero AF; Morbini M; Borghi C
    Expert Opin Pharmacother; 2015 Feb; 16(3):285-8. PubMed ID: 25474717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oily fish reduces plasma triacylglycerols: a primary prevention study in overweight men and women.
    Moore CS; Bryant SP; Mishra GD; Krebs JD; Browning LM; Miller GJ; Jebb SA
    Nutrition; 2006 Oct; 22(10):1012-24. PubMed ID: 17027436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of dietary fats for preventing cardiovascular disease. A review.
    Szostak-Wegierek D; Kłosiewicz-Latoszek L; Szostak WB; Cybulska B
    Rocz Panstw Zakl Hig; 2013; 64(4):263-9. PubMed ID: 24693710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.